Literature DB >> 9105899

Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1).

E Yamato1, H Ikegami, K Takekawa, T Fujisawa, Y Nakagawa, Y Hamada, H Ueda, T Ogihara.   

Abstract

Both glucagon and glucagon-like peptide-1 (GLP-1) play an important role in the regulation of nutrient homeostasis. In this study, the tissue distributions of the expression of receptor genes for glucagon and GLP-1 were examined. Expression of glucagon receptor gene was detected in liver, kidney, ileum and pancreatic islets but not in brain. In contrast, expression of GLP-1 receptor gene was detected in brain, pancreas and pancreatic islets but not in liver, kidney, or ileum. To investigate the existence and characteristics of glucagon and GLP-1 receptors on pancreatic beta cells, expression of the receptor genes and translational regulation of the expression of the receptor genes by glucose were analyzed in a mouse pancreatic beta cell line, MIN6 cells. In the cDNA pool of MIN6 cells, both glucagon and GLP-1 receptor genes were identified and showed higher expression level in MIN6 cells cultured under high glucose condition than in those cultured under low glucose condition. These results suggest that glucagon and GLP-1 receptor genes are expressed in pancreatic beta cells and their expression is upregulated by glucose.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105899     DOI: 10.1055/s-2007-978985

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

1.  Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.

Authors:  Dale S Edgerton; Zhibo An; Kathryn M S Johnson; Tiffany Farmer; Ben Farmer; Doss Neal; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

2.  Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats.

Authors:  Elisabeth L Raab; Patricia M Vuguin; Doris A Stoffers; Rebecca A Simmons
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-21       Impact factor: 3.619

3.  Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat.

Authors:  Indu Poornima; Suzanne B Brown; Siva Bhashyam; Pratik Parikh; Hakki Bolukoglu; Richard P Shannon
Journal:  Circ Heart Fail       Date:  2008-09       Impact factor: 8.790

Review 4.  Obesity and appetite control.

Authors:  Keisuke Suzuki; Channa N Jayasena; Stephen R Bloom
Journal:  Exp Diabetes Res       Date:  2012-08-01

5.  Molecular mechanisms of appetite regulation.

Authors:  Ji Hee Yu; Min-Seon Kim
Journal:  Diabetes Metab J       Date:  2012-12-12       Impact factor: 5.376

6.  The gut hormones in appetite regulation.

Authors:  Keisuke Suzuki; Channa N Jayasena; Stephen R Bloom
Journal:  J Obes       Date:  2011-09-22

7.  GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice.

Authors:  Robert W Schwenk; Christian Baumeier; Brian Finan; Oliver Kluth; Christine Brauer; Hans-Georg Joost; Richard D DiMarchi; Matthias H Tschöp; Annette Schürmann
Journal:  Diabetologia       Date:  2014-12-20       Impact factor: 10.122

Review 8.  The Gut-Brain Axis, the Human Gut Microbiota and Their Integration in the Development of Obesity.

Authors:  Edward S Bliss; Eliza Whiteside
Journal:  Front Physiol       Date:  2018-07-12       Impact factor: 4.566

9.  Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure.

Authors:  Chen Gao; Shuxun Vincent Ren; Junyi Yu; Ulysis Baal; Dung Thai; John Lu; Chunyu Zeng; Hai Yan; Yibin Wang
Journal:  JACC Basic Transl Sci       Date:  2019-03-13

Review 10.  Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids.

Authors:  Habeeb Alhabeeb; Ali AlFaiz; Emad Kutbi; Dayel AlShahrani; Abdullah Alsuhail; Saleh AlRajhi; Nemer Alotaibi; Khalid Alotaibi; Saad AlAmri; Saleh Alghamdi; Naji AlJohani
Journal:  Nutrients       Date:  2021-01-31       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.